Clinical Trial Update: Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating facial actinic keratoses treated with imiquimod 3.75% cream followed by photodynamic therapy; the study was terminated and results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Imiquimod 3.75% Cream (Imiquimod)

Snippet

Sponsor: Tennessee Clinical Research Center | Conditions: Actinic Keratosis | Phase 4 | Status: TERMINATED | Results posted: 2014-11-20